Gary McCall, PA
Medical · Mineola, NYNPI 1174708283
Payments from drug & device makers
Across 66 payments — averaging $24.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$189
- Boehringer Ingelheim$173
- Getinge USA Sales, LLC$146
- Edwards Lifesciences$143
- Irhythm Technologies, Inc.$107
- Merck$96
- plus $754 from 16 others
What the payments were for
- Food & beverage$1,609100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $189 |
| Boehringer Ingelheim | 8 | $173 |
| Getinge USA Sales, LLC | 3 | $146 |
| Edwards Lifesciences | 6 | $143 |
| Irhythm Technologies, Inc. | 2 | $107 |
| Merck | 6 | $96 |
| Amgen | 5 | $92 |
| La Jolla Pharmaceutical Company | 4 | $77 |
| Abiomed | 2 | $68 |
| Bayer | 3 | $58 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $58 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Atricure, Inc. | 1 | $53 |
| Scpharmaceuticals Inc. | 2 | $49 |
| Lexicon Pharmaceuticals, Inc. | 2 | $45 |
| Abbott | 2 | $40 |
| Novartis | 2 | $34 |
| Johnson & Johnson | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Cvrx, Inc. | 1 | $29 |
| Bridgebio Pharma, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $14 |
How this compares
$1,609 in reported general payments places this provider in the 75th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $14,261 |
| Metoprolol Succinate | 121 | $758 |
| ClopidogrelClopidogrel Bisulfate | 82 | $488 |
| Potassium Chloride | 43 | $229 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $136 |
| Amiodarone Hcl | 21 | $116 |
| Atorvastatin Calcium | 15 | $81 |
| Tramadol Hcl | 29 | $73 |
| Furosemide | 37 | $48 |
| Tamsulosin Hcl | 12 | $37 |
| Amlodipine Besylate | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other medical in Mineola
- Jamie WidawskyMineola$36K
- Abim SharmaMineola$23K
- Michael DylagMineola$14K
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.